Related Experiment Video
Updated: Sep 20, 2026
Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
[Septal defects treatment with Amplatzer occluders]
1Servicio de Cardiología Pediátrica, Instituto Nacional de Cardiología Ignacio Chávez Juan Badiano 1, Col. Sección XVI 14080, México, D.F. zabal@cardiologia.org.mx
Insights
Amplatzer occluders effectively treat various cardiac defects, including atrial septal defect and patent ductus arteriosus. This program demonstrates successful outcomes using these devices in pediatric and adult patients.
Area of Science:
- Cardiology
- Medical Devices
Context:
- Since February 1999, a dedicated program has utilized Amplatzer occluders for cardiac defect treatment.
- The study encompasses a significant patient cohort with diverse congenital heart conditions.
Purpose:
- To present the clinical outcomes and efficacy of Amplatzer occluder devices in treating cardiac defects.
- To detail the application of Amplatzer occluders in specific conditions like atrial septal defect and patent ductus arteriosus.
Summary:
- The program treated 118 patients with atrial septal defect, 182 with patent ductus arteriosus, 11 with hypertensive arterial duct (using ventricular septal occluders), and 7 with ventricular septal defect.
- Results with these Amplatzer devices are comprehensively detailed in this communication.
Impact:
- Demonstrates the successful application and outcomes of Amplatzer occluders in a large patient group.
- Provides valuable data for clinicians considering device-based closure for congenital heart defects.
Abstract:
Since February 1999, we started the program to treat cardiac defects with Amplatzer occluders. We have treated 118 patients with atrial septal defect, 182 patients with patent ductus arterious, 11 with hypertensive arterial duct treated with the ventricular septal occluder, and 7 patients with ventricular septal defect. In this communication we detail our results with these devices.
